TY  - JOUR
AU  - Fernandez-Checa, Jose C
AU  - Bagnaninchi, Pierre
AU  - Ye, Hui
AU  - Sancho-Bru, Pau
AU  - Falcon-Perez, Juan M
AU  - Royo, Felix
AU  - Garcia-Ruiz, Carmen
AU  - Konu, Ozlen
AU  - Miranda, Joana
AU  - Lunov, Oleg
AU  - Dejneka, Alexandr
AU  - Elfick, Alistair
AU  - McDonald, Alison
AU  - Sullivan, Gareth J
AU  - Aithal, Guruprasad P
AU  - Lucena, M Isabel
AU  - Andrade, Raul J
AU  - Fromenty, Bernard
AU  - Kranendonk, Michel
AU  - Cubero, Francisco Javier
AU  - Nelson, Leonard J
PY  - 2021
DO  - 10.1016/j.jhep.2021.06.021
UR  - https://hdl.handle.net/10668/27073
T2  - Journal of hepatology
AB  - Drug-induced liver injury (DILI) is a major cause of acute liver failure (ALF) and one of the leading indications for liver transplantation in Western societies. Given the wide use of both prescribed and over the counter drugs, DILI has become a major...
LA  - en
KW  - Acetaminophen
KW  - humanized models
KW  - iPSCs
KW  - liver-on-a-chip
KW  - Acetaminophen
KW  - Chemical and Drug Induced Liver Injury
KW  - Consensus
KW  - Europe
KW  - Humans
KW  - Liver
TI  - Advanced preclinical models for evaluation of drug-induced liver injury - consensus statement by the European Drug-Induced Liver Injury Network [PRO-EURO-DILI-NET].
TY  - research article
VL  - 75
ER  -